Hyaluronic acid combined with L-proline in an intra-articular injectable matrix gel. Replaces lost synovial fluid while supporting the cartilage matrix.
L-proline provides synthesis of the collagen that supports cartilage in the joint system, restraining the enzymes that lead to reduced cartilage production.
| Composition | Sodium hyaluronate + L-proline in phosphate buffer |
|---|---|
| Bond structure | Linear |
| Hyaluronic acid concentration | 10 – 30 mg/mL |
| Variants | 10 · 14 · 15 · 20 · 24 · 25 · 30 mg/mL |
| Syringe | 1 · 2 · 2.5 · 3 · 4 · 5 mL |
| Flacon | 5 mL · 10 mL |
| Dosing | Per physician |
| Buffer | Sodium dihydrogen phosphate · disodium hydrogen phosphate · sodium chloride + L-proline |
| Form | Sterile viscoelastic solution |
| Use | Single use only |
| Shelf life | 2 years |
| Storage | Between 2 °C and 25 °C |
| Marking | CE |
Refer to the Instructions for Use for the full intended purpose, contraindications and warnings.
SkyVisc is a range of four intra-articular grades. Pure is hyaluronic acid alone; + and GGP add actives to the linear gel; Cross is the single cross-linked model. SkyVisc Pure · SkyVisc GGP · SkyVisc Cross · Full SkyVisc range
SkyVisc + is a linear intra-articular gel that combines sodium hyaluronate with L-proline in phosphate buffer.
Pre-filled syringes of 1, 2, 2.5, 3, 4 and 5 mL and flacons of 5 mL and 10 mL, in seven concentrations from 10 to 30 mg/mL.
Between 2 °C and 25 °C. The shelf life is 2 years.
Both are linear gels on the same 10–30 mg/mL range. SkyVisc + adds L-proline to the buffer; SkyVisc Pure contains hyaluronic acid alone.
Technical specifications, regulatory documentation and catalogs are available to qualified partners on request.
Product information is provided for healthcare professionals, distributors and business partners and does not constitute medical advice. Availability, specifications and regulatory status may vary by country.